President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

In a special live episode, What’s up Docs? explores the wonders of the human heart.

A new industry group wants to set aside the piecemeal state-by-state approach imposing food dye and labeling laws in favor of federal control. The opposition has roiled the MAHA coalition.

Placenta accreta is a life-threatening condition in which the placenta attaches to scar tissue left by a C-section. It used to be extremely rare.

Round-the-clock fetal monitoring leads to unnecessary C-sections. But it’s used in nearly every birth because of business and legal concerns, The Times found.

Doctors have already begun reducing radiation treatment for women at low risk of recurrence or spread of the disease. A new study finds that some women at greater risk can safely avoid radiation.

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines.

Prepared pasta sold at grocery chains across the country, including Albertsons and Trader Joe’s, were recalled after people in 18 states became ill, federal health officials said.

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.

New work requirements are expected to leave millions of poor Americans uninsured. For Equifax, which charges states steep prices for its trove of employment data, it is a business opportunity.